Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicity.
2012
Background:During the 2009–2010 influenza pandemic, we evaluated the immunogenicity and safety of different H1N1 2009 pandemic influenza vaccines delivering various viral hemagglutinin (HA) doses with or without AS03 (a tocopherol oil-in-water emulsion–based adjuvant system) in children (NCT00976820
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
15
References
13
Citations
NaN
KQI